Safety and effectiveness of natalizumab: Result from 7th year of the post-marketing surveillance

Authors
Category Primary study
Conference63rd Annual Meeting of the Japanese Society of Neurology
Year 2022
This article has no abstract
Epistemonikos ID: 2eca3446cec723acd951a2d82aeb8d2f2d19ea4e
First added on: Jan 24, 2026